ATATcH Alternating Treatment Plans for Advanced Cancer

NCT05358548 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Lung Cancer

Interventions

DRUG: Paclitaxel
DRUG: Pemetrexed
DRUG: 5Fluorouracil
DRUG: Carboplatin
DRUG: Pembrolizumab

Sponsor

Rutgers, The State University of New Jersey